Meeting
2014 Genitourinary Cancers Symposium
Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study.
Authors
Satoru Ueno
Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Satoru Ueno , Atsushi Mizokami , Takashi Fukagai , Naohiro Fujimoto , Hitoshi Ohoka , Yukihiro Kondo , Gaku Arai , Hisamitsu Ide , Mikio Namiki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 207)
DOI
10.1200/jco.2014.32.4_suppl.207
Abstract #
207
Poster Bd #
B3
Abstract Disclosures
Similar Posters
Poster
2012 Genitourinary Cancers Symposium
Randomized study on the effect of zoledronic acid treatment for prostate cancer with bone metastasis during initial combined androgen blockade.
First Author: Satoru Ueno
Poster
2013 Genitourinary Cancers Symposium
Efficacy and safety of zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: Results of CALGB 90202 (Alliance).
First Author: Matthew Raymond Smith
Poster
2012 Genitourinary Cancers Symposium
Skeletal events unrelated to bone metastasis in men with castration-refractory prostate cancer.
First Author: Kazumi Kamoi
Poster
2021 ASCO Annual Meeting
The efficacy of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) on bone oligometastatic hormone-sensitive prostate cancer: A post hoc analysis of ARCHES.
First Author: Andrew J. Armstrong